OBAT Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Brigit Biofarmaka Teknologi Tbk PT

Watchlist Manager

Watchlist

Price: 242 IDR -0.82% Market Closed

Market Cap: Rp164.7B

B	Brigit Biofarmaka Teknologi Tbk PT IDX:OBAT	ID
	Putra Mandiri Jembar Tbk PT IDX:PMJS	ID
	Djurslands Bank A/S CSE:DJUR	DK
R	Royalite Petroleum Company Inc OTC:RYPE	US
I	Imprendiroma SpA F:Y37	IT
	China Yuchai International Ltd NYSE:CYD	SG
	Iren SpA OTC:IRDEF	IT
	Permian Resources Corp F:YZ8	US
B	Bridge Biotherapeutics Inc KOSDAQ:288330	KR
K	Kandal M Venture Ltd NASDAQ:FMFC	KH
	Active Energy Group PLC OTC:AEUSF	UK
	ECS Botanics Holdings Ltd ASX:ECS	AU
S	Sabre Insurance Group PLC F:18M	UK

Profitability Summary

Brigit Biofarmaka Teknologi Tbk PT's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

37%

Sustainable 3Y Average Gross Margin

42%

Healthy Operating Margin

18%

Sustainable 3Y Average Operating Margin

24%

Healthy Net Margin

11%

Sustainable 3Y Average Net Margin

17%

Healthy Free Cash Flow Margin

Negative 3Y Average Free Cash Flow Margin

-1%

Positive ROE

16%

Exceptional 3Y Average ROE

48%

Positive ROIC

25%

Exceptional 3Y Average ROIC

55%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.